ClinicalTrials.gg
CompletedNCT00755664Updated Jun 8, 2015

Effects of Low-dose Complex B-vitamins on Homocysteine and Framingham Risk Score Among Chinese Elderly

A Phase 3 interventional study of Low-dose complex B-vitamins in Hyperhomocysteinemia, sponsored by Peking University. Completed at 1 site in China. Open to participants aged 60 Years to 74 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-06-08.

Sponsored by Peking University · Phase 3, Interventional, and Prevention

Phase
Phase 3
Study type
Interventional
Enrollment
390
Allocation
Randomized
Ages
60 Years to 74 Years
Sex
All
01

Study summary

The purpose of this study is to evaluate whether low dose complex B-vitamins (folic acid,vitamin B6 and vitamin B12) can lower the risk of developing hyperhomocysteinemia in an apparently healthy population with low folate/B12 and high Hcy status.

Read the detailed description

Hyperhomocysteinemia has been well known as an independent risk factor for CVD. Numerous studies have demonstrated that certain kinds of vitamin B(folic acid,vitamin B6 and vitamin B12)can reduce Hcy level and may prevent CVD. However, the majority of those studies has been conducted always used high dose vitamin in patient or high risk population. There is thus absence of data that the effectiveness of low dose complex B-vitamins on the apparently Chinese elderly population with relative sub-nutritional status. Our study is just focus on the aforementioned aspect.

02

Conditions studied

  • Hyperhomocysteinemia

Browse trials for

Keywords

  • homocysteine
  • folate acid,
  • vitamin B
  • random controlled trail
03

In context

Hyperhomocysteinemia

34 studies on the registry are indexed under Hyperhomocysteinemia; 4 are open to participants now.

This study's enrollment of 390 is above the median of 84 across 21 interventional studies indexed under Hyperhomocysteinemia.

Browse Hyperhomocysteinemia studies →

Lead sponsor

Peking University is the lead sponsor of 419 studies on the registry; 123 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years to 74 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male and female residents living in the field site for at least 12 months
  • Aged 60-74 years

Exclusion criteria

Exclusion Criteria:

  • History of chronic disease and taking medications for treatment such as CVD, , cancer, severe renal and liver disease, diabetes.
  • Use of multivitamins, and individual vitamins such as folic acid, B12, or B6 in the last 6 months.
  • Taking medications known to interfere with folate metabolism, including methotrexate, tamoxifen, L-DOPA, niacin, phenytoin, bile acid sequestrants; anticonvulsant medications (such as dilantin, phenytoin, and primidone), Metformin, Sulfasalazine.
  • Conditions that prevent participation or compliance such as Downs syndrome, mental problems, or severe cognitive impairment
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

05

Study design

Phase
Phase 3
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
390 participants (actual)

Study arms

  • Active comparator
    Low-dose complex B-vitamins

    Intervention group receives Low-dose complex B-vitamins every day. Low-dose complex B-vitamins contain 400µg of folic acid, 2mg of vitamin B6, 10µg of vitamin B12 and 50mg vitamin C. Daily supplementation lasts for 12 months

    Dietary Supplement: Low-dose complex B-vitamins

  • Placebo comparator
    Vitamin C

    Control group receives Vitamin C (50mg)every day. Daily supplementation lasts for 12 months.

    Dietary Supplement: Low-dose complex B-vitamins

Interventions

  • Dietary supplementLow-dose complex B-vitamins

    The complex B vitamins supplement has been made as capsule and packaging 31 capsules in 1 bottle with a pre-determined code number on its cover. The main content contains either vitamin C 50mg alone or combination with folate 0.4 mg, vitamin B6 2mg, vitamin B12 10μg and vitamin C 50 mg. Two kinds of the supplements could not be discriminated by appearance, smell, taste, size and package.volunteers in either arms are required to take 1 capsule per day and last for 48 weeks.

    Also known as: vitamin supplement

06

What researchers measure

Primary outcomes

  1. plasma homocysteine level, plasma folate acid and red blood cell folate acid, Framingham risk score

    Time frame: 6,12 and 18 months

Secondary outcomes

  1. systolic blood pressure, diastolic blood pressure and hemoglobin

    Time frame: 6 and 12 months

Other outcomes

  1. folate receptor antibodies

    Time frame: 6 months

  2. genetic variants

    Time frame: 6 months

07

Study locations

1 site
  • The maternal and Children health care hospital
    Yuanshi county of Shijiazhuang, Hebei 050000, China
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 8, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00755664
Lead sponsor
Peking University
Collaborators
Institute of reproductive and Child Health, National Natural Science Foundation of China
Responsible party
Liu Jianmeng (Institute of reproductive and Child Health, Peking University) — Principal investigator
First posted
Sep 19, 2008
Start date
Jul 2007
Primary completion
Sep 2012
Completion
Sep 2012
Last update
Jun 8, 2015

Study contacts

Jianmeng Liu, Prof.
principal investigator · Institute of reproductive and Child health, PUHSC

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Vitamin Supplement

Start the discussion